Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Idexx Laboratories (IDXX) and ImmunityBio (IBRX)
ImmunityBio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Healthcare Services (HCSG) and ImmunityBio (IBRX)
ImmunityBio (IBRX) Gets a Hold From Piper Sandler
Analysts Conflicted on These Healthcare Names: Masimo (MASI), ImmunityBio (IBRX) and Madrigal Pharmaceuticals (MDGL)
ImmunityBio Analyst Ratings
Piper Sandler Reaffirms Their Hold Rating on ImmunityBio (IBRX)
ImmunityBio (IBRX) Gets a Buy From Jefferies
ImmunityBio Downgraded to Neutral at Piper on Bladder Cancer Candidate
Piper Sandler Downgrades ImmunityBio to Neutral, Lowers Price Target to $4
Jefferies Starts ImmunityBio at Buy With $8 Price Target
ImmunityBio Price Target Announced at $8.00/Share by Jefferies
ImmunityBio Initiated at Buy by Jefferies
ImmunityBio analyst ratings
Jefferies Initiates Coverage On ImmunityBio with Buy Rating, Announces Price Target of $8
Piper Sandler Adjusts ImmunityBio's Price Target to $10 From $20, Reiterates Overweight Rating